Noted molecular biologist James Bliska, PhD, is joining the Geisel School of Medicine at Dartmouth as a Distinguished Professor in Microbiology and Immunology and senior lead faculty member of the Personalized Treatments for Cystic Fibrosis (CF) Cluster, a cross-Dartmouth group of investigators established to develop innovative, personalized medicine and treatments for CF and lung infections caused by opportunistic pathogens.
Articles by: Timothy Dean
Two outstanding graduate student researchers at the Geisel School of Medicine, Heidi Chapman and Riley Hampsch, are gaining knowledge and skills in the biotechnology sector as recipients of 2017 Dartmouth SYNERGY/Celdara Medical High-Potential Entrepreneurs’ Fellowships.
Experiences such as working as a volunteer on medical mission trips to Honduras and practicing as an oncology nurse in Arizona helped Meghan Bullock ’20 decide that medical school was the right path for her.
Meet some of the members of the Geisel School of Medicine’s Class of 2021—KC Collier, Tianrae Chu, and Allie Morgan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine.
Meet some of the members of the Geisel School of Medicine’s Class of 2021—Sand Mastrangelo, Shuaibu Ali, Sylvia Guerra, and Meredith Ryan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine
A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Ninety-two members of the Geisel School of Medicine’s 221st class were enthusiastically welcomed to Hanover by the Dartmouth community as part of this year’s orientation for incoming medical students, which runs from August 7-11.
Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.
Dartmouth SYNERGY Scholars prepares young clinical scientists for success in today’s highly competitive research environment.
A team of Dartmouth researchers has found that mothers who have developed antibodies against the herpes simplex virus (HSV-1) can pass these antibodies to the nervous systems of their infants, protecting them from acquiring the virus.